In This Section      
Print This Page

A Message for Our Valued Oncology Patients

We are proud to announce that as of 1 Nov 2017, oncology services, physicians and nurses will transition to Tan Tock Seng Hospital (“TTSH”), a member of the National Healthcare Group.

Read more



At Johns Hopkins Singapore, research is regarded as the key driving force behind our multidisciplinary, innovative and pioneering investigations that ultimately determines our success in providing world-renowned medical education and unsurpassed patient care to all of our patients.

It is through research that we are able to discover the risks and further understand the causes of cancer, especially those that are most prevalent in the Asia-Pacific region: liver cancer and nasopharyngeal cancer. Research has the ability to help us detect cancer earlier and develop less invasive therapies, which can provide our patients with cancer with a better quality of life during and after treatment.

Our investigators are also participating in a number of pharmaceutical studies to develop new drugs at the international level to help patients gain early access to new medication.

Our efforts in the field of cancer research are an ongoing process, and we will continue to keep you informed of our latest studies. We hope that the resources listed in the other sections will help you find the services you need in order to continue contributing to the growth of this field.

Annual Scientific Research Report 2016

Read more about how the research team at Johns Hopkins Singapore provides unparalleled excellence in their search for ground breaking treatment options

News From Johns Hopkins Medicine

Toughest Breast Cancer May Have Met Its Match

The cells that form triple-negative breast cancer tumors lack three proteins that would make the cancer respond to powerful, customized treatments. But now, researchers have discovered a way that breast cancer cells are able to resist the effects of chemotherapy—and a way to reverse that process.

Johns Hopkins Scientists Link Gene to Tamoxifen-Resistant Breast Cancers

After mining the genetic records of thousands of breast cancer patients, researchers from the Johns Hopkins Kimmel Cancer Center have identified a gene whose presence may explain why some breast cancers are resistant to tamoxifen, a widely used hormone treatment generally used after surgery, radiation and other chemotherapy.